Celldex Therapeutics Profile

2.92
USD 0.05  1.68%
2.86Last Month High 3.03 
2.87Trading Day  High 3.02 

Payment of 3212 shares by Gerald McMahon of Celldex Therapeutics subject to Rule 16b-3

Celldex Therapeutics Inc insider trading alert for payment of common stock par value $0.001 per share by Gerald McMahon, the corporate stakeholder, on December 1, 2017. This event was filed by Celldex Therapeutics Inc with SEC on 2017-12-01. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Celldex Therapeutics Summary

Celldex Therapeutics Inc (CLDX) is traded on NASDAQ in USA. It is located in NEW JERSEY, U.S.A and employs 196 people. Celldex Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 405.24 M. Celldex Therapeutics Inc has 135.98 M outstanding shares of which 7.89 M shares are currently shorted by private and institutional investors with about 5.82 trading days to cover. CELLDEX THERAPEUT currently holds about 140.53 M in cash with (100.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03.
Check Celldex Therapeutics Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares9.7 M27.6 M
Fmr LlcCommon Shares8.9 M25.6 M
View Celldex Therapeutics Diagnostics

Selected Celldex Therapeutics Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Celldex Therapeutics Against Markets

Current Ratings  

Celldex Therapeutics 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
4 
Chance of
< 67% 
Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameCelldex Therapeutics Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationNEW JERSEY, U.S.A
Business AddressCelldex Therapeutics, Inc.Hampton, NJ
ExchangeNASDAQ
CIK Number00744218.0
CUSIP15117B103
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.celldextherapeutics.com
Contact Number908 200 7500
CurrencyUSD - US Dollar

Recommendations

Celldex Therapeutics Analyst Recommendations
Target PriceAdvice# of Analysts
6.0Buy4Odds
Celldex Therapeutics Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Celldex Therapeutics Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Celldex Therapeutics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.33March 14, 2017
Celldex Therapeutics Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate